Trending...
- City Of Boston Licensing Board Approves 21 New Liquor Licenses
- Mayor Wu Appoints New Commissioners To Boston Civic Design Commission
- Boston: Mayor Michelle Wu Joins Federal and State Leaders to Celebrate the Start of Construction of the Redevelopment of the Mary Ellen McCormack Public Housing
~ Veeva Systems, a leading cloud software company for the life sciences industry, has announced a major advancement in clinical trial execution with the latest release of Veeva Site Connect. This new release includes powerful capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration.
According to Veeva, this new release will significantly reduce the time and effort required for site start-up, study conduct, and closeout. This will result in higher-quality trials at a lower cost for sponsors.
One of the key features of Veeva Site Connect is its ability to provide easy access to all necessary information for sites in just a few clicks. By standardizing how information is shared across all sites in one application, Veeva aims to save time and effort that can be focused on treating patients.
A clinical operations excellence leader at a top 20 biopharmaceutical company stated, "Our goal is to eliminate manual handoffs and inefficiencies for faster site start-up, more efficient monitoring, and simplified study closeout."
To achieve better trial execution in less time, Veeva Site Connect has expanded its capabilities beyond document exchange and safety distribution. It now includes Study Communications, Contacts, Payment Information, and quick links to sponsor systems.
More on Boston Chron
The user interface for sites has also been optimized with an intuitive homepage and simple sidebar navigation. This means that sites can easily stay informed and complete tasks with just a few clicks. Additionally, having the same user experience for all trials allows for a standard way of working across sponsors.
Veeva Site Connect is accessible for all sites globally. Sites that use Veeva SiteVault as their electronic Investigator Site File (eISF) will also benefit from seamless bidirectional document exchange.
With a fixed fee engagement of two to four months (depending on company size), sponsors can quickly implement Veeva Site Connect and make significant progress towards their goal of faster, higher quality trial execution.
Alisha Garibaldi, CEO of Skylight Health Research, expressed her enthusiasm for Veeva Site Connect, stating, "I would be ecstatic if all our sponsors use Veeva Site Connect. It gives sites a much more efficient way to collaborate with sponsors, maintain regulatory compliance, and get critical therapies to patients faster."
Marta Jureczko-Hinzmann, head of global clinical solution services at AstraZeneca, also shared her excitement for the new release. She stated, "By implementing Veeva Site Connect for our safety letter distribution process, we anticipate achieving a significant reduction in manual processing while enhancing oversight and compliance."
More on Boston Chron
Veeva Site Connect is part of Veeva Clinical Platform, a complete and connected solution that supports patients, sites, and sponsors. As the industry moves towards simplifying and standardizing site collaboration, seven of the top 20 biopharmaceutical companies have already adopted Veeva Site Connect to streamline their trials.
To learn more about Veeva Site Connect and see a demo of its capabilities, interested parties can attend the Veeva R&D and Quality Summit on September 9-10 in Boston. At this event, top biopharmaceutical companies will share how they use Veeva Site Connect to simplify trial execution for greater quality and speed.
For additional information on Veeva Site Connect, visit veeva.com/VeevaSiteConnect or connect with Veeva on LinkedIn at linkedin.com/company/veeva-systems.
About Veeva Systems:
Veeva Systems is a global leader in cloud software for the life sciences industry. With a commitment to innovation, product excellence, and customer success, Veeva serves over 1,000 customers ranging from large biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation (PBC), Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
According to Veeva, this new release will significantly reduce the time and effort required for site start-up, study conduct, and closeout. This will result in higher-quality trials at a lower cost for sponsors.
One of the key features of Veeva Site Connect is its ability to provide easy access to all necessary information for sites in just a few clicks. By standardizing how information is shared across all sites in one application, Veeva aims to save time and effort that can be focused on treating patients.
A clinical operations excellence leader at a top 20 biopharmaceutical company stated, "Our goal is to eliminate manual handoffs and inefficiencies for faster site start-up, more efficient monitoring, and simplified study closeout."
To achieve better trial execution in less time, Veeva Site Connect has expanded its capabilities beyond document exchange and safety distribution. It now includes Study Communications, Contacts, Payment Information, and quick links to sponsor systems.
More on Boston Chron
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Mikel DeFrancesco Named RealTrends Top Realtor in Quincy, Milton & South Shore MA
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
The user interface for sites has also been optimized with an intuitive homepage and simple sidebar navigation. This means that sites can easily stay informed and complete tasks with just a few clicks. Additionally, having the same user experience for all trials allows for a standard way of working across sponsors.
Veeva Site Connect is accessible for all sites globally. Sites that use Veeva SiteVault as their electronic Investigator Site File (eISF) will also benefit from seamless bidirectional document exchange.
With a fixed fee engagement of two to four months (depending on company size), sponsors can quickly implement Veeva Site Connect and make significant progress towards their goal of faster, higher quality trial execution.
Alisha Garibaldi, CEO of Skylight Health Research, expressed her enthusiasm for Veeva Site Connect, stating, "I would be ecstatic if all our sponsors use Veeva Site Connect. It gives sites a much more efficient way to collaborate with sponsors, maintain regulatory compliance, and get critical therapies to patients faster."
Marta Jureczko-Hinzmann, head of global clinical solution services at AstraZeneca, also shared her excitement for the new release. She stated, "By implementing Veeva Site Connect for our safety letter distribution process, we anticipate achieving a significant reduction in manual processing while enhancing oversight and compliance."
More on Boston Chron
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Verdane Invests in Guardsquare to Scale Mobile Security Solutions for All Businesses
- Holland America Line Marks America's 250th Anniversary in 2026 with Cruise to Historical U.S. Ports
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
Veeva Site Connect is part of Veeva Clinical Platform, a complete and connected solution that supports patients, sites, and sponsors. As the industry moves towards simplifying and standardizing site collaboration, seven of the top 20 biopharmaceutical companies have already adopted Veeva Site Connect to streamline their trials.
To learn more about Veeva Site Connect and see a demo of its capabilities, interested parties can attend the Veeva R&D and Quality Summit on September 9-10 in Boston. At this event, top biopharmaceutical companies will share how they use Veeva Site Connect to simplify trial execution for greater quality and speed.
For additional information on Veeva Site Connect, visit veeva.com/VeevaSiteConnect or connect with Veeva on LinkedIn at linkedin.com/company/veeva-systems.
About Veeva Systems:
Veeva Systems is a global leader in cloud software for the life sciences industry. With a commitment to innovation, product excellence, and customer success, Veeva serves over 1,000 customers ranging from large biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation (PBC), Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Filed Under: Business
0 Comments
Latest on Boston Chron
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Boston: Mayor Wu Announces Second Year of City-wide Participatory Budgeting Initiative
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- City Of Boston Licensing Board Approves 21 New Liquor Licenses
- New Report Highlights Increasing Demand for Technology-Driven Solutions Across the Real Estate Market
- The Atlantic Resilency Innovation Institute Deploys First Coastal Sensor for Emergency Response
- Boston: Mayor Wu Joins Federal and State Leaders to Celebrate Start of the Mary Ellen McCormack Public Housing Redevelopment Construction
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- City of Boston Licensing Board Approves 21 New Liquor Licences
- Boston: Mayor Michelle Wu Joins Federal and State Leaders to Celebrate the Start of Construction of the Redevelopment of the Mary Ellen McCormack Public Housing
- Mayor Wu Appoints New Commissioners To Boston Civic Design Commission
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Boston: Community, Personal Fitness, and Social Wellness in July